$NCSM

Hummer Ryan sold (to issuer) 48,389 shares of NCSM

Hummer Ryan (See Remarks) sold (to issuer) 48,389 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Hummer Ryan
Published Sep 1, 2026, 1:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
high confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The sale is modest and unlikely to affect market perception of NCSM.

02

Market read

A routine insider sale with minimal market impact.

03

What to watch

Potential upcoming capital raise that prompted the insider to liquidate his position.

Relevance 4/10Novelty 4/10Timing: same-day filing

Background

Form 4 disclosures provide the first public record of insider transactions.

Company-level read

Ticker impact

$NCSMNeutralHigh confidence
Context

Officer Hummer Ryan sold 48,389 shares of NCS Multistage Holdings, reducing his stake to zero.

Expected impact

No significant price change expected.

Evidence & confidence

The transaction size is small relative to market cap and the insider is exiting completely, which typically has limited market impact.

Market effects

No broader sector impact; the filing is company‑specific.

Limited to investors tracking NCSM.

None

Counterpoint

If the insider exit signals hidden concerns, a short‑term sell pressure could emerge.

Key entities

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

  • Hummer Ryan

    Officer and director who sold the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).